December 21, 2016

Appili Therapeutics Raises $2.2M in Equity Capital to Develop Its Anti-Infective Pipeline

October 3, 2016

Appili Therapeutics Inc. Appoints Kimberly Stephens as Chief Financial Officer

May 25, 2016

Appili Raises $3.2M in Seed Round To Develop Novel Antibiotics

April 12, 2016

Appili Receives Orphan Drug Designation from FDA for ATI-1501: Treating C. difficile in Children